ReviewBiomedicines2022

Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.

Hanan Kamel M Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.